{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:55Z","timestamp":1792788055508,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaac.2026.10.017","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:24:26Z","timestamp":1792682666000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cariprazine in the Treatment of Pediatric Patients With Irritability Associated With Autism Spectrum Disorder: A Randomized Controlled Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-5782","authenticated-orcid":false,"given":"Robert L.","family":"Findling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durim","family":"Bozhdaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5261-9659","authenticated-orcid":false,"given":"Walt","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-2641","authenticated-orcid":false,"given":"Jeffrey R.","family":"Strawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-3293","authenticated-orcid":false,"given":"Manpreet K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-7066","authenticated-orcid":false,"given":"Marc S.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0606-2528","authenticated-orcid":false,"given":"Ludmyla","family":"Rekeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3580-3463","authenticated-orcid":false,"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3805-3055","authenticated-orcid":false,"given":"Mousam","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3187-3256","authenticated-orcid":false,"given":"Marshall","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7402a1","article-title":"Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years \u2014 Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States, 2022","volume":"74","author":"Shaw","year":"2025","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jaac.2026.10.017_bib2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Neurodevelopmental Disorders. In: Diagnostic and Statistical Manual of Mental Disorders (5th Ed.). 2013. doi:10.1176\/appi.books.9780890425787.x01_neurodevelopmental_disorders","DOI":"10.1176\/appi.books.9780890425787.x01_Neurodevelopmental_Disorders"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s10803-020-04627-9","article-title":"Assessing Irritability in Children with Autism Spectrum Disorder Using the Affective Reactivity Index","volume":"51","author":"Kalvin","year":"2021","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/aur.70100","article-title":"Trajectory of Irritability in Autistic and Typically Developing Youth From Early Childhood to Adolescence","author":"Calub","year":"2025","journal-title":"Autism Res"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1192\/bjp.147.2.127","article-title":"Irritability: Definition, Assessment and Associated Factors","volume":"147","author":"Snaith","year":"1985","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaac.2026.10.017_bib6","unstructured":"Aman MG, Singh NN. Aberrant Behavior Checklist Manual (Second Edition). Slosson Educational Publications, Inc.; 2017. https:\/\/www.slossonnews.com\/abc.html"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib7","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10803-013-1970-0","article-title":"Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder","volume":"44","author":"Kaat","year":"2014","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rasd.2019.02.001","article-title":"Psychometric characteristics of the aberrant behavior checklist in a well-defined sample of youth with autism Spectrum disorder","volume":"62","author":"Norris","year":"2019","journal-title":"Res Autism Spectr Disord"},{"issue":"10","key":"10.1016\/j.jaac.2026.10.017_bib10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10803-006-0327-3","article-title":"Factor Analysis of the Aberrant Behavior Checklist in Individuals with Autism Spectrum Disorders","volume":"37","author":"Brinkley","year":"2007","journal-title":"J Autism Dev Disord"},{"issue":"8","key":"10.1016\/j.jaac.2026.10.017_bib11","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s10803-023-05981-0","article-title":"Autistic Symptoms, Irritability, and Executive Dysfunctions: Symptom Dynamics from Multi-Network Models","volume":"54","author":"Lee","year":"2024","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.rasd.2021.101740","article-title":"Associations between domains of health-related quality of life and co-occurring emotional and behavioral problems in youth with autism spectrum disorder","volume":"82","author":"Menezes","year":"2021","journal-title":"Res Autism Spectr Disord"},{"issue":"1","key":"10.1016\/j.jaac.2026.10.017_bib13","first-page":"1","article-title":"Longitudinal Associations between Early Childhood Irritability and Adolescent Depression Symptoms in Autistic Children are Mediated by Peer Relationships but Not Educational Engagement","volume":"36","author":"Leno","year":"2023","journal-title":"Dev Psychopathol"},{"issue":"1","key":"10.1016\/j.jaac.2026.10.017_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chc.2013.08.002","article-title":"Examination of Aggression and Self-injury in Children with Autism Spectrum Disorders and Serious Behavioral Problems","volume":"23","author":"Carroll","year":"2014","journal-title":"Child Adolesc Psychiatr Clin North Am"},{"issue":"9","key":"10.1016\/j.jaac.2026.10.017_bib15","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10803-020-04625-x","article-title":"Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder","volume":"51","author":"Bradshaw","year":"2021","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10803-024-06567-0","article-title":"Parent Training for Disruptive Behaviors in Referred Children with Autism Spectrum Disorder: A Randomized Controlled Trial","volume":"56","author":"Breider","year":"2026","journal-title":"J Autism Dev Disord"},{"issue":"15","key":"10.1016\/j.jaac.2026.10.017_bib17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/jama.2015.3150","article-title":"Effect of Parent Training vs Parent Education on Behavioral Problems in Children With Autism Spectrum Disorder: A Randomized Clinical Trial","volume":"313","author":"Bearss","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jaac.2026.10.017_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5498\/wjp.v13.i6.262","article-title":"Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials","volume":"13","author":"Hellings","year":"2023","journal-title":"World J Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2026.10.017_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2174\/1570159X18666200529151741","article-title":"Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis","volume":"19","author":"Mano-Sousa","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"37","author":"Pandina","year":"2007","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib21","unstructured":"Squibb BM. Abilify (aripiprazole) tablets: US prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021436s038,021713s030,021729s022,021866s023lbl.pdf"},{"issue":"11","key":"10.1016\/j.jaac.2026.10.017_bib22","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.3390\/ijms25115682","article-title":"D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside","volume":"25","author":"Barab\u00e1ssy","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jaac.2026.10.017_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/cap.2022.0097","article-title":"Cariprazine in Pediatric Patients with Autism Spectrum Disorder: Results of a Pharmacokinetic, Safety and Tolerability Study","volume":"33","author":"Yeung","year":"2023","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"10.1016\/j.jaac.2026.10.017_bib24","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.4088\/JCP.15m09997","article-title":"Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial","volume":"76","author":"Durgam","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"2-3","key":"10.1016\/j.jaac.2026.10.017_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.schres.2016.06.030","article-title":"Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial","volume":"176","author":"Durgam","year":"2016","journal-title":"Schizophr Res"},{"issue":"03","key":"10.1016\/j.jaac.2026.10.017_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: A double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2026.10.017_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/appi.ajp.2018.18070824","article-title":"Cariprazine treatment of bipolar depression: A randomized double-blind placebo-controlled phase 3 study","volume":"176","author":"Earley","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2026.10.017_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bdi.12852","article-title":"Efficacy and safety of cariprazine in bipolar I depression: A double\u2010blind, placebo\u2010controlled phase 3 study","volume":"22","author":"Earley","year":"2020","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2024.08.119","article-title":"Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data","volume":"366","author":"Vieta","year":"2024","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.jaac.2026.10.017_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.2015.15020164","article-title":"An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression","volume":"173","author":"Durgam","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2026.10.017_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2017.03.032","article-title":"Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II\/III studies","volume":"215","author":"Earley","year":"2017","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.jaac.2026.10.017_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.64719\/pb.4578","article-title":"Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"48","author":"Earley","year":"2018","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/YIC.0000000000000246","article-title":"Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder","volume":"34","author":"Vieta","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jaac.2026.10.017_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/appi.ajp.20220504","article-title":"Adjunctive cariprazine for the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled phase 3 study","volume":"180","author":"Sachs","year":"2023","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib35","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14643","article-title":"Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study","volume":"84","author":"Riesenberg","year":"2023","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaac.2026.10.017_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jad.2024.04.084","article-title":"Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder","volume":"358","author":"Citrome","year":"2024","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib37","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15506","article-title":"Efficacy of Adjunctive Cariprazine on Anxiety Symptoms in Patients With Major Depressive Disorder","volume":"86","author":"Fava","year":"2025","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/YIC.0000000000000500","article-title":"Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis","volume":"39","author":"Jain","year":"2024","journal-title":"Int Clin Psychopharmacol"},{"issue":"Pt B","key":"10.1016\/j.jaac.2026.10.017_bib39","article-title":"Trajectories and predictors of depressive and anxiety symptom improvement with adjunctive cariprazine in antidepressant-treated adults with major depression: A Bayesian mega-analysis of two randomized trials","volume":"394","author":"Strawn","year":"2026","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.jaac.2026.10.017_bib40","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00213-021-05851-6","article-title":"Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder","volume":"238","author":"Rom\u00e1n","year":"2021","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.jaac.2026.10.017_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/cap.2021.0139","article-title":"Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia","volume":"32","author":"Riccobene","year":"2022","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"10.1016\/j.jaac.2026.10.017_bib42","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib43","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.jaac.2026.10.017_bib44","doi-asserted-by":"crossref","unstructured":"Farmer C, Aman MG. Encyclopedia of Autism Spectrum Disorders. Published online 2017:1-8. doi:10.1007\/978-1-4614-6435-8_1632-3","DOI":"10.1007\/978-1-4614-6435-8_1632-3"},{"issue":"1","key":"10.1016\/j.jaac.2026.10.017_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s41687-021-00396-w","article-title":"The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder","volume":"5","author":"Andel","year":"2021","journal-title":"J Patient-Rep Outcomes"},{"key":"10.1016\/j.jaac.2026.10.017_bib46","doi-asserted-by":"crossref","unstructured":"Zitman FG, Mennen MFG, Griez E, Hooijer C. ECDEU Assessment Manual for Psychopharmacology. Vol 9. (Guy W, ed.). US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976. doi:10.1007\/978-3-642-75373-2_4","DOI":"10.1007\/978-3-642-75373-2_4"},{"key":"10.1016\/j.jaac.2026.10.017_bib47","doi-asserted-by":"crossref","unstructured":"Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, Revised 1976. US Department of Heath, Education, and Welfare; National Institute of Mental Health; 1976.","DOI":"10.1037\/e591322011-001"},{"issue":"9","key":"10.1016\/j.jaac.2026.10.017_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaac.2018.10.016","article-title":"Development of the Parent-Rated Anxiety Scale for Youth With Autism Spectrum Disorder","volume":"58","author":"Scahill","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1-2","key":"10.1016\/j.jaac.2026.10.017_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10488-012-0412-1","article-title":"Measurement Quality of the Caregiver Strain Questionnaire-Short Form 7 (CGSQ-SF7)","volume":"39","author":"Brannan","year":"2012","journal-title":"Adm Polic Ment Heal Ment Heal Serv Res"},{"issue":"4","key":"10.1016\/j.jaac.2026.10.017_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/106342669700500404","article-title":"The Caregiver Strain Questionnaire","volume":"5","author":"Brannan","year":"1997","journal-title":"J Emot Behav Disord"},{"key":"10.1016\/j.jaac.2026.10.017_bib51","doi-asserted-by":"crossref","DOI":"10.2196\/59475","article-title":"Telebehavioral Health for Caregivers of Children With Behavioral Health Needs to Address Caregiver Strain: Cohort Study","volume":"7","author":"Loo","year":"2024","journal-title":"JMIR Pediatr Parent"},{"issue":"8","key":"10.1016\/j.jaac.2026.10.017_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jaac.2017.05.018","article-title":"Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED)","volume":"56","author":"Caporino","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2026.10.017_bib53","unstructured":"Findling R, Correll CU, Singh MK, et al. Characterization of Treatment Emergent Adverse Events With Cariprazine in Pediatric Patients With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder: An Interim Analysis of Safety From a Long-Term Open Label Study. November 6, 2025."},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in Children with Autism and Serious Behavioral Problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jaac.2026.10.017_bib55","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jagp.2017.02.022","article-title":"Variation in Placebo Effect Sizes in Clinical Trials of Oral Interventions for Management of the Behavioral and Psychological Symptoms of Dementia (BPSD): A Systematic Review and Meta-Analysis","volume":"25","author":"Hyde","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"10.1016\/j.jaac.2026.10.017_bib56","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1097\/j.pain.0000000000000333","article-title":"Increasing placebo responses over time in U.S. clinical trials of neuropathic pain","volume":"156","author":"Tuttle","year":"2015","journal-title":"PAIN"},{"issue":"12","key":"10.1016\/j.jaac.2026.10.017_bib57","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jamapsychiatry.2014.1319","article-title":"Placebo Response in Antipsychotic Clinical Trials: A Meta-analysis","volume":"71","author":"Rutherford","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2026.10.017_bib58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/schbul\/sbn110","article-title":"What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?","volume":"36","author":"Kemp","year":"2010","journal-title":"Schizophr Bull"},{"issue":"14","key":"10.1016\/j.jaac.2026.10.017_bib59","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaac.2026.10.017_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1352\/1944-7558-125.5.369","article-title":"Racial and Ethnic Differences in Behavioral Problems and Medication Use Among Children With Autism Spectrum Disorders","volume":"125","author":"Quebles","year":"2020","journal-title":"Am J Intellect Dev Disabil"},{"issue":"2","key":"10.1016\/j.jaac.2026.10.017_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaac.2022.03.033","article-title":"Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response","volume":"62","author":"Pablo","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2026.10.017_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5765\/jkacap.240026","article-title":"Managing Aggressive Behavior in Adolescents With Autism Spectrum Disorder: Pharmacological and Non-Pharmacological Approaches","volume":"35","author":"Purba","year":"2024","journal-title":"J Korean Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856726022008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856726022008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:19:51Z","timestamp":1792786791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856726022008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":62,"alternative-id":["S0890856726022008"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2026.10.017","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cariprazine in the Treatment of Pediatric Patients With Irritability Associated With Autism Spectrum Disorder: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2026.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Academy of Child and Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}